Evaluation of Bortezomib-Induced Neuropathy Using Total Neuropathy Score (Reduced and Clinical Versions) and NCI CTCAE v4.0 in Newly Diagnosed Patients With Multiple Myeloma Receiving Bortezomib-Based…

Overview of attention for article published in Clinical Lymphoma, Myeloma & Leukemia, July 2017

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 20,444 followers.

RT @Myeloma_Doc: Total Neuropathy Score-reduced & -clinical may measure #Velcade-related neuropathy in #myeloma better than CTCAE: https://…

Evaluation of Bortezomib-Induced Neuropathy Using Total Neuropathy Score (Reduced and Clinical Versions) and NCI ... https://t.co/PHyvjL8Bht

Total Neuropathy Score-reduced & -clinical may measure #Velcade-related neuropathy in #myeloma better than CTCAE: https://t.co/DchuG8DaX3. https://t.co/nENkrGpjE0

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.